GLP-1 drugs, like semaglutide, lower risk of hospitalizations for alcohol use disorder
A long-term study suggests GLP-1 agonists, especially semaglutide, may lower the risk of alcohol use disorder hospitalizations, highlighting the potential ...
A long-term study suggests GLP-1 agonists, especially semaglutide, may lower the risk of alcohol use disorder hospitalizations, highlighting the potential ...
A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a ...
In a pioneering study, stem-cell-derived corneal implants improve sight for patients with severe vision impairment, offering a potential breakthrough for ...
Johnson & Johnson has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for BALVERSA®▼ (erdafitinib) ...
Pancreatic ductal adenocarcinoma (PDAC) is recognized as one of the most lethal cancers, with an estimated five-year survival rate of ...
A novel discovery in the field of pancreatic cancer treatment has been unveiled, revealing the epigenetic silencing of BEND4 as ...
A new study reveals how C210, a curcumin derivative, selectively reactivates Epstein–Barr virus to kill cancer cells without infectious risks, ...
The SynGAP Research Fund 501(c)(3) has awarded a pair of grants to Dr. Clement Chow, a geneticist and Associate Professor ...
New study reveals that men rely on opioid-based systems to relieve pain while women may use unknown pathways, urging the ...
Groundbreaking research uncovers the role of miRNAs in driving cancer while offering innovative diagnostic tools and therapies, including solutions to ...
Sepoy.net is a perfect place for people who want daily updates on news related to business, technology, entertainment, health, cryptocurrency etc.
Contact: hello@sepoy.net
© 2023 Sepoy.net